Inhibition of JNK signaling with the specific inhibitor SP600125 prevented bardoxolone methyl-induced JNK activation, DR expression, caspase-8 activation, and DNA fragmentation, suggesting that bardoxolone methyl promotes apoptosis in lung cancer cells via JNK-dependent upregulation of death receptors [110]. This evidence concerns the gene MAPK8 and lung cancer.